<?xml version="1.0" encoding="UTF-8"?>
<p>Indeed, the use of the current viral load algorithm in case of failure is very low: in the OPP-ERA project, less than 15% of patients with viral load at least 1000 copies/ml benefited from a viral load control within 3â€“6 (or 9) months and second-line switch is anecdotal (personal data), as shown in previous study [
 <xref rid="R5" ref-type="bibr">5</xref>]. These problems should be explored before any new recommendations.
</p>
